O'Shaughnessy Ventures Backs Researcher Bringing Clinical Trials to Patients' Homes

Fengyi Zheng awarded an O'Shaughnessy Fellowship to replace subjective, geography-dependent motor function assessments with AI-powered home testing

GREENWICH, Conn., April 2, 2026 /PRNewswire/ -- O'Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators, has awarded an O'Shaughnessy Fellowship to Fengyi Zheng, a biomedical researcher and founder based in Boston, Massachusetts.

Zheng will use the fellowship to continue building BioMe, a platform that uses AI-powered motion tracking to measure motor function from at-home videos. BioMe turns home-recorded footage into study-ready measurements, removing the geographic barriers that limit who can participate in clinical trials and replacing subjective in-clinic assessments with more objective, consistent data.

A mathematics and statistics graduate of the University of Wisconsin-Madison, Zheng previously conducted research at the Broad Institute of MIT and Harvard, where her work on CRISPR technology was published in the journals Cell Genomics and Nature Communications. She was also selected as a Broad Biomedical Post-Baccalaureate Scholar. She has since developed a working prototype of BioMe using open-source computer vision models.

OSV's founder and CEO, Jim O'Shaughnessy, commented, "The quality of clinical trial data influences which treatments reach patients and who those patients are. Fengyi is tackling that problem from the ground up. We're thrilled to support her in taking BioMe to the next level."

"I'm grateful for the O'Shaughnessy Fellowship and excited to be joining this community," said Zheng. "Underrepresented and biased data in healthcare are among the most important problems we face. They shape which treatments get built and who they actually work for. I look forward to working on this alongside a rigorous, diverse community that genuinely cares about the world."

About the O'Shaughnessy Fellowships Program

Launched in 2023, the O'Shaughnessy Fellowships program discovers and empowers the world's boldest creatives, builders and researchers. Fellows receive a grant of up to $100,000 and gain access to OSV's network of founders, investors and experts. OSV will award up to 20 fellowships in 2026.

Zheng is the first fellow announced in 2026. More information about previous years' fellows is available at OSV's website.

Applications for the O'Shaughnessy Fellowships remain open through April 30, 2026. Individuals interested in applying can do so via OSV's website.

About O'Shaughnessy Ventures

OSV is a creative investment firm that empowers creators to bring their ideas to life. Founded by Jim O'Shaughnessy, a pioneer in quantitative investing, founder of O'Shaughnessy Asset Management, and author of five books, OSV aims to provide financial support and to partner in growing the next life-changing creative ideas.

OSV combines Jim's deeply rooted interest in all things art, science, investing and technology with his long-held desire to establish scenarios designed to help promising creators and their inspiring ideas succeed, regardless of age, location, job history or level of education. For more information, visit OSV's website.

Media Contact:
Ena Gong
O'Shaughnessy Ventures LLC
(917) 355-7420
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/oshaughnessy-ventures-backs-researcher-bringing-clinical-trials-to-patients-homes-302732318.html

SOURCE O'Shaughnessy Ventures